GeneDx Historical Financial Ratios
| WGSWW Stock | 0.16 0.01 5.88% |
GeneDx Holdings is recently reporting on over 80 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 3.98, Dividend Yield of 0.0, PTB Ratio of 8.85 or Days Sales Outstanding of 62.26 will help investors to properly organize and evaluate GeneDx Holdings Corp financial condition quickly.
GeneDx |
About GeneDx Financial Ratios Analysis
GeneDx Holdings CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate GeneDx Holdings investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on GeneDx financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across GeneDx Holdings history.
GeneDx Holdings Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing GeneDx Holdings Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on GeneDx Holdings sales, a figure that is much harder to manipulate than other GeneDx Holdings Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Most ratios from GeneDx Holdings' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into GeneDx Holdings Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in GeneDx Holdings Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. At this time, GeneDx Holdings' Shareholders Equity Per Share is fairly stable compared to the past year. Graham Net Net is likely to climb to 0.02 in 2025, whereas Free Cash Flow Yield is likely to drop (0.02) in 2025.
| 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 5.68 | 13.86 | 13.96 | 7.23 | Days Of Inventory On Hand | 19.08 | 22.57 | 35.0 | 40.04 |
GeneDx Holdings fundamentals Correlations
Click cells to compare fundamentals
GeneDx Holdings Account Relationship Matchups
High Positive Relationship
High Negative Relationship
GeneDx Holdings fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 3.16E-4 | 2.27 | 0.38 | 0.33 | 6.77 | 3.98 | |
| Free Cash Flow Yield | (2.2K) | (0.44) | (3.74) | (2.78) | (0.0164) | (0.0173) | |
| Operating Cash Flow Per Share | (599.0K) | (58.15) | (31.18) | (7.41) | (1.06) | (1.11) | |
| Stock Based Compensation To Revenue | 0.67 | 1.03 | 0.18 | (0.001609) | 0.0299 | 0.0284 | |
| Free Cash Flow Per Share | (804.6K) | (64.49) | (32.58) | (7.64) | (1.26) | (1.33) | |
| Net Income Per Share | (1.6M) | (74.93) | (53.63) | (7.23) | (1.94) | (2.04) | |
| Sales General And Administrative To Revenue | 0.56 | 0.97 | 0.87 | 0.66 | 0.33 | 0.47 | |
| Research And Ddevelopement To Revenue | 0.41 | 0.5 | 0.37 | 0.29 | 0.15 | 0.14 | |
| Capex To Revenue | 0.18 | 0.098 | 0.061 | 0.0282 | 0.018 | 0.0171 | |
| Pocfratio | (6.08E-4) | (2.53) | (0.28) | (0.37) | (72.53) | (68.9) | |
| Interest Coverage | (97.81) | (157.37) | (208.19) | 7.66 | 8.8 | 9.24 | |
| Capex To Operating Cash Flow | (0.34) | (0.11) | (0.0449) | (0.0317) | (0.19) | (0.2) | |
| Pfcf Ratio | (4.53E-4) | (2.28) | (0.27) | (0.36) | (60.81) | (57.77) | |
| Income Quality | 0.39 | 0.78 | 0.58 | 1.02 | 0.55 | 0.53 | |
| Pe Ratio | (2.3E-4) | (1.96) | (0.16) | (0.38) | (39.53) | (37.55) | |
| Earnings Yield | (4.4K) | (0.51) | (6.16) | (2.63) | (0.0253) | (0.0266) | |
| Capex Per Share | 205.6K | 6.35 | 1.4 | 0.23 | 0.2 | 0.19 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.